Henry M. Sucov

Dr. Henry M. Sucov

Department of Regenerative Medicine and Cell Biology and Department of Medicine Division of Cardiology, Medical University of South Carolina, Charleston, SC 29425, USA
orcid

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2002 in Developmental Biology
Verified
Journal Article
Closed access
XJXiaobing Jiang
Xiaobing Jiang
SISachiko Iseki
Sachiko Iseki
RMRobert E. Maxson
Robert E. Maxson
Henry M. SucovHenry M. Sucov
Henry M. Sucov
GMGillian M. Morriss-Kay
Gillian M. Morriss-Kay

1 March 2001 in Mechanisms of Development
Verified
Journal Article
Closed access
XWXiantuo Wu
Xiantuo Wu
JWJian Wu
Jian Wu
JHJiapeng Huang
Jiapeng Huang
WPWilliam C. Powell
William C. Powell
JZJianFeng Zhang
JianFeng Zhang
PRPradip Roy-Burman
Pradip Roy-Burman

7 August 2017 in Nature Genetics
Verified
Journal Article
Open access
PDF file
MPMichaela Patterson
Michaela Patterson
LBLindsey Barske
Lindsey Barske
BHBen Van Handel
Ben Van Handel
CRChristoph D Rau
Christoph D Rau
PGPeiheng Gan
Peiheng Gan
Henry M. SucovHenry M. Sucov
Henry M. Sucov
Henry Sucov and colleagues demonstrate substantial natural variation in the capacity of the mouse heart to regenerate after injury and link this to the prevalence of mononuclear diploid cardiomyocytes. They identify Tnni3k as one gene that contributes to the observed variation and validate its role through mouse knockout and zebrafish overexpression studies. Adult mammalian cardiomyocyte regeneration after injury is thought to be minimal. Mononuclear diploid cardiomyocytes (MNDCMs), a relatively small subpopulation in the adult heart, may account for the observed degree of regeneration, but this has not been tested. We surveyed 120 inbred mouse strains and found that the frequency of adult mononuclear cardiomyocytes was surprisingly variable (>7-fold). Cardiomyocyte proliferation and heart functional recovery after coronary artery ligation both correlated with pre-injury MNDCM content. Using genome-wide association, we identified Tnni3k as one gene that influences variation in this composition and demonstrated that Tnni3k knockout resulted in elevated MNDCM content and increased cardiomyocyte proliferation after injury. Reciprocally, overexpression of Tnni3k in zebrafish promoted cardiomyocyte polyploidization and compromised heart regeneration. Our results corroborate the relevance of MNDCMs in heart regeneration. Moreover, they imply that intrinsic heart regeneration is not limited nor uniform in all individuals, but rather is a variable trait influenced by multiple genes.

1 December 1998 in Neuron
Verified
Journal Article
Closed access
MCMing-Yi Chiang
Ming-Yi Chiang
DMDinah Misner
Dinah Misner
GKGerd Kempermann
Gerd Kempermann
TSThomas Schikorski
Thomas Schikorski
VGVincent Giguere
Vincent Giguere
RERonald M Evans
Ronald M Evans

1 May 2011 in Development
Verified
Journal Article
Closed access
PDF file
PLPeng Li
Peng Li
SCSusana Cavallero
Susana Cavallero
YGYing Gu
Ying Gu
TCTim H. P. Chen
Tim H. P. Chen
JHJennifer Hughes
Jennifer Hughes
Henry M. SucovHenry M. Sucov
Henry M. Sucov
Secreted factors from the epicardium are believed to be important in directing heart ventricular cardiomyocyte proliferation and morphogenesis, although the specific factors involved have not been identified or characterized adequately. We found that IGF2 is the most prominent mitogen made by primary mouse embryonic epicardial cells and by a newly derived immortalized mouse embryonic epicardial cell line called MEC1. In vivo, Igf2 is expressed in the embryonic mouse epicardium during midgestation heart development. Using a whole embryo culture assay in the presence of inhibitors, we confirmed that IGF signaling is required to activate the ERK proliferation pathway in the developing heart, and that the epicardium is required for this response. Global disruption of the Igf2 gene, or conditional disruption of the two IGF receptor genes Igf1r and Insr together in the myocardium, each resulted in a significant decrease in ventricular wall proliferation and in ventricular wall hypoplasia. Ventricular cardiomyocyte proliferation in mutant embryos was restored to normal at E14.5, concurrent with the establishment of coronary circulation. Our results define IGF2 as a previously unexplored epicardial mitogen that is required for normal ventricular chamber development.

24 February 2009 in Hepatology
Verified
Journal Article
Open access
PDF file
KAKinji Asahina
Kinji Asahina
STShirley Y. Tsai
Shirley Y. Tsai
PLPeng Li
Peng Li
MIMamoru Ishii
Mamoru Ishii
RMRobert E. Maxson
Robert E. Maxson
HTHidekazu Tsukamoto
Hidekazu Tsukamoto
The knowledge concerning fetal hepatic stellate cells (HSCs) is scarce, and their cell lineage and functions are largely unknown. The current study isolated fetal liver mesenchymal cells from a mouse expressing β-galactosidase under the control of Msx2 promoter by fluorescence-activated cell sorting (FACS) and surveyed marker genes by microarray analysis. Based on the location and immunostaining with conventional and newly disclosed markers, we have identified three distinct populations of fetal liver mesenchymal cells expressing both desmin and p75 neurotrophin receptor (p75NTR): HSCs in the liver parenchyma; perivascular mesenchymal cells expressing α-smooth muscle actin (α-SMA); and submesothelial cells associated with the basal lamina beneath mesothelial cells and expressing activated leukocyte cell adhesion molecule (ALCAM) and platelet-derived growth factor receptor α. A transitional cell type from the submesothelial cell phenotype to fetal HSCs was also identified near the liver surface. Mesothelial cells expressed podoplanin and ALCAM. Ki-67 staining showed that proliferative activity of the submesothelial cells is higher than that of mesothelial cells and transitional cells. Using anti-ALCAM antibodies, submesothelial and mesothelial cells were isolated by FACS. The ALCAM+ cells expressed hepatocyte growth factor and pleiotrophin. In culture, the ALCAM+ cells rapidly acquired myofibroblastic morphology and α-SMA expression. The ALCAM+ cells formed intracellular lipid droplets when embedded in collagen gel and treated with retinol, suggesting the potential for ALCAM+ cells to differentiate to HSCs. Finally, we demonstrated that fetal HSCs, submesothelial cells, and perivascular mesenchymal cells are all derived from mesoderm by using MesP1-Cre and ROSA26 reporter mice. Conclusion: Fetal HSCs, submesothelial cells, and perivascular mesenchymal cells are mesodermal in origin, and ALCAM+ submesothelial cells may be a precursor for HSCs in developing liver. (HEPATOLOGY 2009.)